Symbol
CLDI on NYSE
Investment type
Equity / Common Stock, $0.0001 par value
Latest Disclosed Shares Owned
700,000 shares
Security Ownership %
9.8%

Gavrilov Ognian Anguelov ownership in Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

09 Mar 2026 - Gavrilov Ognian Anguelov has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 700,000 shares of Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI). This represents 9.8% ownership of the company. In their previous filing dated 04 Feb 2026, Gavrilov Ognian Anguelov had reported owning 560,000 shares, indicating an increase of +25%. .